# E3311 (NCT01898494)

> Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01898494
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: ECOG-ACRIN Cancer Research Group
- Conditions: Human Papilloma Virus Infection; Stage III Squamous Cell Carcinoma of the Oropharynx; Stage IVA Squamous Cell Carcinoma of the Oropharynx; Stage IVB Squamous Cell Carcinoma of the Oropharynx
- Interventions: Transoral surgery; intensity-modulated radiation therapy; cisplatin; carboplatin
- Enrollment: 519
- Primary outcome: Progression-free Survival Rate at 2 Years
- Primary outcome: Proportion of Patients With Grade III or IV Oropharyngeal Bleeding or Positive Margins

## Indexed commentary on E3311 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 14
- YouTube: 3
- Podcasts: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=e3311-nct01898494

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01898494", "email": "<work email>"}; the inbox owner confirms by the emailed link.